5:57 PM
 | 
Sep 20, 2013
 |  BC Extra  |  Company News

Obesity, pain drugs approved in Japan

Norgine B.V. (Amsterdam, the Netherlands) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Oblean cetilistat to treat obesity in patients with...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >